TITLE

USE OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT AS A BRIDGE TO TRANSPLANTATION IN FULMINANT HEPATIC FAILURE DUE TO BUDD-CHIARI SYNDROME

AUTHOR(S)
Shrestha, Roshan; Durham, Janette D.; Wachs, Michael; Bilir, Bahri M.; Kam, Igal; Trouillot, Thomas; Everson, Gregory T.
PUB. DATE
December 1997
SOURCE
American Journal of Gastroenterology;Dec1997, Vol. 92 Issue 12, p2304
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
We report a case of fulminant hepatic failure in a 55-yr-old man due to Budd-Chiari syndrome in the setting of polycythemia rubra vera. The patient presented with acute hepatic failure, which rapidly progressed to grade IV hepatic encephalopathy. Placement of a transjugular intrahepatic portosystemic shunt resulted in marked improvement of the encephalopathy and stabilized the liver failure. Subsequently, he underwent successful nonemergent orthotopic liver transplantation. Transjugular intrahepatic portosystemic shunt placement is a safe, effective, therapeutic option to bridge patients with fulminant Budd-Chiari to liver transplantation.
ACCESSION #
16444147

 

Related Articles

  • Fulminant Hepatic Failure. Fingerote, Robert J.; Bain, Vincent G. // American Journal of Gastroenterology;Jul1993, Vol. 88 Issue 7, p1000 

    Fulminant hepatic failure (FHF) is defined as acute liver failure with hepatic encephalopathy in patients with no history or stigmata of chronic liver disease. Historically, its prognosis was extremely poor. However, the emergence of orthotopic liver transplantation as a viable form of therapy...

  • A Comparison of Paracentesis and Transjugular Intrahepatic Portosystemic Shunting in Patients with Ascites. Rössle, Martin; Ochs, Andreas; Gülberg, Veit; Siegerstetter, Volker; Holl, Joseph; Deibert, Peter; Olschewski, Manfred; Reiser, Maximilian; Gerbes, Alexander L. // New England Journal of Medicine;06/08/2000, Vol. 342 Issue 23, p1701 

    Background: In patients with cirrhosis and ascites, creation of a transjugular intrahepatic portosystemic shunt may reduce the ascites and improve renal function. However, the benefit of this procedure as compared with that of large-volume paracentesis is uncertain. Methods: We randomly assigned...

  • Fulminant hepatic failure in woman with iron and non-steroidal anti-inflammatory drug intoxication. Magdalan, Jan; Zawadzki, Marcin; Sozański, Tomasz // Human & Experimental Toxicology;Aug2011, Vol. 30 Issue 8, p1106 

    A 17-year-old, previously healthy female ingested 16,000 mg iron sulphate (96.15 mg of iron ions per kg of b.wt.) with a suicidal intent. The patient was admitted to a toxicology unit 10 hours after the drug ingestion. Serum iron concentration at admission was 2351 μg% (421.0 μmol/L). In...

  • Artificial Liver Support -- Pipe Dream or Reality? Cattral, Mark S.; Levy, Gary A. // New England Journal of Medicine;7/28/94, Vol. 331 Issue 4, p268 

    The article presents information on fulminant hepatic failure including its treatments, and characteristics. Fulminant hepatic failure is characterized by the rapid appearance of jaundice, coagulopathy, and encephalopathy and reflects severe hepatocellular injury or necrosis. It is stated that...

  • A Systematic Review on Prognostic Indicators of Acute Liver Failure and Their Predictive Value for Poor Outcome. Wlodzimirow, Kama A.; Eslami, Saeid; Abu-Hanna, Ameen; Nieuwoudt, Martin; Chamuleau, Robert A. F. M. // British Journal of Medicine & Medical Research;5/21/2014, Vol. 4 Issue 15, p2796 

    Aims: To systematically identify and summarize prognostic indicators in patients with acute liver failure and to evaluate their predictive value. To analyse a wide spectrum of indicators used worldwide for prediction of outcome in patients with acute liver failure as a starting point for a...

  • Reversibility of hepatic encephalopathy after liver transplantation. Atluri, Dileep K.; Asgeri, Mehrdad; Mullen, Kevin D. // Metabolic Brain Disease;Mar2010, Vol. 25 Issue 1, p111 

    Until the advent of Liver transplantation, it was widely believed that Hepatic Encephalopathy (HE) was usually reversible. The exceptions were the so called “Acquired Hepatocerebral Degeneration cases” which were considered irreversible. Paradoxically, it seems, with liver...

  • New strategies for treating hepatic encephalopathy. Gómez-Gutiérrez, Cristina; Manzano-Robleda, María C.; Uribe, Misael; Méndez-Sánchez, Nahum // Annals of Hepatology: Official Journal of the Mexican Associatio;2014, Vol. 13 Issue 3, p409 

    The article comments on the use of new techniques in treating hepatic encephalopathy (HE), a serious neuropsychiatric complication of both acute and chronic liver disease. The role of ammonia accumulation has ed explanations of the pathogenesis of HE. General management of HE focuses on...

  • Chlorzoxazone.  // Reactions Weekly;10/27/2007, Issue 1175, p11 

    The article describes the case of a 48-year-old woman who developed fulminant liver failure during treatment with chlorzoxazone for shoulder pain. On examination, the woman, who had been receiving chlorzoxazone three times daily for the last 4 months, had scleral jaundice and a tender right...

  • Antworten zu den Fragen zu « Akutes Leberversagen » aus PRAXIS Nr. 20.  // Praxis (16618157);10/16/2013, Vol. 102 Issue 21, p1327 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics